Another Indian company Ranbaxy announced it’s joint venture with Community Investment Holdings ( a South African firm). Ranbaxy holds 70% of the venture, named Sonke Pharmaceuticals. This will allow Ranbaxy to sell their anti-Hiv drugs in Africa at a lower cost. They plan to market their drugs not only in South Africa, but also in Namibia and Botswana. Sonke Pharmaceuticals hopes to provide HIV-positive people in these countries with a cheap and effective treatment through public and private facilities.